Information about Voglibose

    Voglibose uses

    Voglibose is used in the treatment of type 2 diabetes.

    How voglibose works

    Voglibose is active in the small intestine, where it inhibits enzymes which are responsible for the breakdown of complex sugar into simple sugars such as glucose. Which thereby slows the digestion of sugar in the intestines and primarily lowers the post-meal rise in blood sugar levels.

    Common side effects of voglibose

    Skin rash, Flatulence, Abdominal pain, Diarrhoea

    Available Medicine for Voglibose

    • ₹80 to ₹115
      Sun Pharmaceutical Industries Ltd
      3 variant(s)
    • ₹120 to ₹264
      Sun Pharmaceutical Industries Ltd
      4 variant(s)
    • ₹55 to ₹206
      4 variant(s)
    • ₹70 to ₹95
      USV Ltd
      2 variant(s)
    • ₹80 to ₹119
      Torrent Pharmaceuticals Ltd
      2 variant(s)
    • ₹76 to ₹104
      Alembic Pharmaceuticals Ltd
      2 variant(s)
    • ₹84 to ₹108
      Lupin Ltd
      3 variant(s)
    • ₹70 to ₹104
      Medley Pharmaceuticals
      2 variant(s)
    • ₹81 to ₹107
      Micro Labs Ltd
      2 variant(s)
    • ₹65 to ₹106
      Macleods Pharmaceuticals Pvt Ltd
      2 variant(s)

    Expert advice for Voglibose

    • It is very common to have flatulence, abdominal pain, diarrhoea as a side effect. To prevent this it should be taken just before each meal.
    • It may cause low blood sugar level (hypoglycemia) if used with sulfonylureas.
    • You should avoid using bile acid resins and antacids with Voglibose.
    • Inform your doctor if you have ever been diagnosed with chronic intestinal disorders, hernias, intestinal obstruction and intestinal ulcers.
    • Inform your doctor if you have ever been diagnosed with kidney or liver disease. Dose of your medicine may need to be adjusted.

    Frequently asked questions for Voglibose


    Q. Can I use Voglibose for weight loss?
    No. Voglibose is not approved for weight loss. It can produce weight loss on prolonged use due to inhibition of carbohydrate digestion and delayed gastric emptying. It is used in the treatment of type 2 diabetes mellitus with post-prandial hyperglycemia.
    Q. Voglibose should not be used in which condition?
    Voglibose should not be used in patients with inflammatory bowel disease, colonic ulceration, intestinal obstruction, or chronic intestinal disease and in patients with severe hepatic impairment.
    Q. Can I use Voglibose with insulin?
    Yes. Voglibose can be used along with Insulin. It may potentiate the hypoglycemic effects of insulin, so the dosages of these agents may need to be changed accordingly.
    Show More
    Q. What would be the benefit to taking Pioglitazone vs Voglibose?
    Pioglitazone gives a better control of blood sugar as compared to Voglibose.
    Q. Which class of drug Voglibose belongs?
    Voglibose belongs to the class of drug known as an alpha-glucosidase inhibitor.
    Q. How to use Voglibose?
    Voglibose are taken orally and should be chewed with the first mouthful of food, or swallowed whole with a little liquid directly before the meal. It is only effective in patients eating complex carbohydrates as they delay glucose absorption until further along the digestive tract.
    Q. Why is Voglibose safer than acarbose?
    Voglibose has less chance of causing flatulence and gastrointestinal side effects than acarbose.
    Q. Can I take Voglibose and metformin in combination?
    Yes. Voglibose can be taken with metformin.

    Content on this page was last updated on 24 August, 2017, by Dr. Varun Gupta (MD Pharmacology)